Children’s Hospital Colorado has led in research and the development of innovative treatment programs for liver disease, HIV/AIDS, cancer, and genetic conditions such as cystic fibrosis. Additionally, Children’s Hospital Colorado serves residents of its community and beyond as a resource for the treatment of blood disorders such as hemophilia.
U.S. News & World Report consistently places the facility’s Center for Cancer and Blood Disorders (CCBD) among its 10 leading programs working to combat pediatric cancer. Children’s Hospital Colorado’s Hemophilia and Thrombosis Center is a part of this internationally recognized CCBD program.
The Hemophilia and Thrombosis Center offers treatment plans focused on the needs of children with life-threatening clotting disorders such as hemophilia, as well as with abnormalities in platelet function, afibrinogenemia, and von Willebrand disease in addition to a range of other less-common conditions. Children’s Hospital Colorado offers a full complement of family support services and, when necessary, involves social workers and physical therapists.